Antifungal dosing in critically ill patients

被引：1
|
作者：
Bergman S.J. [1 ]
Tyagi I. [1 ]
Ronald K. [1 ]
机构：
[1] Division of Infectious Diseases, Southern Illinois University School of Medicine, Springfield, IL 62794, 701 North 1st Street
来源：
Current Fungal Infection Reports | 2010年 / 4卷 / 2期
关键词：
Amphotericin B; Anidulafungin; Antifungals; Caspofungin; Combinations; Critical care; Dose; Echinocandin; Fluconazole; Flucytosine; ICU; Itraconazole; Lipid formulations; Micafungin; Pharmacodynamics; Pharmacokinetics; Posaconazole; Triazole; Voriconazole;
D O I：
10.1007/s12281-010-0012-z
中图分类号：
学科分类号：
摘要：
This article reviews appropriate dosing for antifungals and emphasizes factors specific to the critically ill patient, along with drug pharmacokinetics and pharmacodynamics. The rationale for doses of the echinocandins (caspofungin, micafungin, anidulafungin), triazoles (fluconazole, voriconazole, itraconazole, posaconazole), amphotericin B (including lipid formulations), and flucytosine are discussed. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码：78 / 86
页数：8
相关论文
共 50 条
  • [31] Antibiotic dosing in critically ill patients with acute kidney injury
    Rachel F. Eyler
    Bruce A. Mueller
    [J]. Nature Reviews Nephrology, 2011, 7 : 226 - 235
  • [32] Dialysis dosing in critically ill patients with acute kidney injury
    Humes, H. David
    Ding, Feng
    Song, Joon Ho
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (04) : 649 - 652
  • [33] The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
    Marta Ulldemolins
    Jason A. Roberts
    Jordi Rello
    David L. Paterson
    Jeffrey Lipman
    [J]. Clinical Pharmacokinetics, 2011, 50 : 99 - 110
  • [34] Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients
    Bai, Jing
    Wen, Aiping
    Li, Zhe
    Li, Xingang
    Duan, Meili
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (05) : 434 - 439
  • [35] The Relevance of Drug Clearance to Antibiotic Dosing in Critically Ill Patients
    Roberts, Darren M.
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2002 - 2014
  • [36] Evaluation of the Hartford Nomogram for dosing of aminoglycosides in critically ill patients
    Kiser, Tytee H.
    Fish, Douglas N.
    Wilson, Christopher G.
    Jorgensen, Jennifer M.
    Beavers, Kathryn D.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : A116 - A116
  • [37] Vancomycin dosing in critically ill trauma patients: The VANCTIC Study
    Villanueva, Ruben D.
    Talledo, Oscar
    Neely, Stephen
    White, Bryan
    Celii, Amanda
    Cross, Alisa
    Kennedy, Ryan
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2019, 87 (05): : 1164 - 1171
  • [38] EVALUATION OF DEXMEDETOMIDINE DOSING ON TEMPERATURE IN OBESE CRITICALLY ILL PATIENTS
    Atyia, Sara
    Gerlach, Anthony
    Smetana, Keaton
    Thompson, Molly
    May, Casey
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 484 - 484
  • [39] Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration
    Aguilar, Gerardo
    Ramon Azanza, Jose
    Carbonell, Jose A.
    Ferrando, Carlos
    Badenes, Rafael
    Asuncion Parra, Maria
    Sadaba, Belen
    Navarro, David
    Puig, Jaume
    Minana, Amanda
    Garcia-Marquez, Carlos
    Gencheva, Gergana
    Gutierrez, Andrea
    Marti, Francisco J.
    Javier Belda, F.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (06) : 1620 - 1623
  • [40] Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients
    Grucz, Traci M.
    Kruer, Rachel M.
    Bernice, Fidelia
    Lipsett, Pamela A.
    Dorman, Todd
    Sugrue, David
    Jarrell, Andrew S.
    [J]. SURGICAL INFECTIONS, 2020, 21 (10) : 859 - 864
12345